Abstract
Previous chapters have detailed the findings in acute nonlymphocytic leukemia (ANLL) de novo and in the blast phase of chronic granulocytic leukemia (CGL-BP). In this chapter we will discuss the morphologic, ultrastructural, and cytochemical characteristics of therapy-related or secondary myelodysplastic syndromes (2°-MDS) and ANLL (2°-ANLL), and we will compare these features with those of ANLL de novo and CGL-BP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pedersen-Bjergaard J, Larsen SO. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin’s disease. New Engl J Med 307: 965–971, 1982.
Coleman CN, Burke J, Varghese A, Rosenburg S, Kaplan H. Secondary leukemia and non-Hodgkins lymphoma in patients treated for Hodgkins disease. In: Rosenberg S, Kaplan H. eds. Malignant lymphomas, Bristol Myers Cancer Symposia. vol 3. New York: Academic Press, 1982.
Greene MH, Boice JD, Greer BE, Blessing J A, Dembo AJ. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: A study of five randomized clinical trials. New Engl J Med 307: 1416–1421, 1982.
Bergsagel DE, Bailey AJ, Langley GR, Mac Donald RN. White DF, Miller AB. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia. New Engl J Med 301: 743–748, 1979.
Bergsagel DE, Bailey AJ, Langley GR, Mac Donald RN. White DF, Miller AB. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia. New Engl J Med 301: 743–748, 1979.
Albain KS, LeBeau MM, Rowley JD, Golomb HM, Vardiman JW. Secondary acute nonlymphocytic leukemia (ANLL) and dysmyelopoietic syndrome (DMPS) in 46 patients: Clinical and cytogenetic correlations. Blood 60 isuppl 1): 119a. 1982, abstract 405.
Bennett JM, Catovsky D, Daniel MT, Flandrin G. Galton DAG. Gralnick HR, Sultan C. The French-American-British (FAB) Co-operative Group: Proposals for the classification of the myelodysplasia syndromes. Br J Haematol 51: 189–199, 1982.
Rowley JD, Golomb HM. Vardiman JW. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 58:759–767, 1981.
Vardiman JW. Golomb HM. Rowley JD, Variakojis D. Acute nonlymphocytic leukemia in malignant lymphoma: A morphologic study. Cancer 42: 229–242, 1978.
Casciato DA, Scott JL. Acute leukemia following prolonged cytotoxic agent therapy. Medicine 58: 32–47, 1979.
Cadman EC. Capizzi RL. Bertino JR Acute nonlymphocytic leukemia: A delayed complication of Hodgkin’s disease therapy. Analysis of 109 cases. Cancer 40: 1280–1296, 1977.
Grunwald HW, Rosner F. Acute myeloid leukemia following treatment of Hodgkin’s disese: A review. Cancer 50: 676–683, 1982.
Pedersen-Bjergaard J, Philip P. Mortensen BT, Ersboll J. Jensen G, Panduro J, Thomsen M. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases: Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing. Blood 57: 712–723, 1981.
Dohy H. Genot JY, Imbert M, D’Agay MFR, Sultan C. Myelodysplasia and leukaemia related to chemotherapy and/or radiotherapy: A haematological study of 13 cases. Value of macrocytosis as an early sign of bone marrow injury. Clin Lab Haematol 2: 111–119, 1980.
Foucar K. McKenna RW, Bloomficld CD, Bowers TK, Brunning RD. Therapy- related leukemia: A panmyelosis. Cancer 43: 1285–1296, 1979.
O’Donnel JF. Brereton HD, Greco FA. Gralnick HR, Johnson RE. Acute nonlymphocytic leukemia achronic lymphocytic leukemia: Clinical studies. Cancer 44: 1930–1938, 1979.
McKenna RW, Parkin JL. Foucar K. rerunning RD. Ultrastructural characteristics of therapy-related acute nonlymphocytic leukemia: Evidence for a panmyelosis. Cancer 48: 723–737, 1981.
Renoux M, Bernard J, Torres M, Schlegel N, Amar M, Lopez M, Boivin P. Erythrocyte abnormalities induced by chemotherapy and radiotherapy: Induction of preleukaemic states? Scand I Haematol 21: 323–332. 1978.
Pierre R, Sultan C, Vardiman J. Themyelodysplasric syndromes. In: McArthur JR. Hillman RS. eds. Hematology. 1982. Education Program of American Society of Hematology. The American Society of Hematology. 1982.
Vardiman JW, Coelho A. Golomb HM. Rowley J. Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol, 79: 525–530. 1983.
Kitahara M, Cosgriff TM, Eyre HJ. Sideroblastic anemia as a preleukemic event in patients treated for Hodgkin’s disease. Ann Intern Med 92: 625–627. 1980.
Sultan C. Sigaux F, Imbert M, Reyes F. Acute myelodysplasia with myelofibrosis: A report of eight cases. Br J Haematol 49: 11–16, 1981.
Butler AE. Vardiman JW. Golomb HM. Ultrastructural characterization of de novo and secondary leukemias. Virchows Arch Cell Pathol39: 239–257, 1982.
Wickramasinghe SN. Bush V. Electron microscope and high resolution autoradiographic studies of megaloblastic erythropoiesis. Acta Haematol 57: 1–14. 1977.
Lewis SM. Frisch B. Congenital dyserythropoietic anemia: Electron microscopy. In: Porter R, Fitzsimons DW, eds. Congenital disorders of erythropoiesis. Ciba Foundation Symposium 37. Amsterdam, 1976.
Breton-Gorius J, Reyes F. Duhamel F. Najman A, Gorin NC. Megakarvoblastic acute leukemia: Identification by the ultrastructural demonstration of platelet peroxidase. Blood 51: 45–60, 1978.
Bennett JM. Catovsky D. Daniel M. Flandrin G, Galton DAG. Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias: French-American-British (FAB) Co-operative Group. Br J Haematol 33: 451–458. 1976.
Lewis SM, Szur I. Malignant myelosclerosis Br Med J 2: 472–477, 1963.
Bearman RM. Pangalis GA. Rappaport H. Acute (“malignant”) myelosclerosis. Cancer 43: 279–293, 1979.
Kaplan DR. Chao FC. Stiles CD. Antoniades HN, Scher CD Platelet a granules contain a growth factor for fibroblasts. Blood 53: 1043–1052, 1979.
Groopman JE. The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92: 857–858. 1980.
Breton-Gorius J. Bizet M, Reyes F, Dupuy E, Mear C, Vannier J, Tron P. Myelofibrosis and acute megakaryoblastic leukemia in a child: Topographic relationship between fibroblasts and megakaryocytes with an or-granule defect. Leuk Res 6: 97–110. 1982.
Bain BJ. Catovsky D, O’Brien M, Prentice HG, Lawlor E, Kumaran TO. McCann SR. Matures E. Galton DAG. Megakaryoblastic leukemia presenting as acute myelofibrosis: A study of four cases with the platelet- peroxidase reaction. Blood 58 206–213, 1981.
Den Ottolander GJ. te Velde J. Brederoo P. Geraedts PM. Slee PHT. Willemze R. Zwaan FE, Haak HL. Muller HP, Bieger R. Megakaryoblastic leukemia (acute myelofibrosis): A report of three cases. Br F Haematol 42: 9–20. 1979.
Berger R. Bernheim A. Daniel M, Valensi F. Sigaux F, Flandrin G. Cytologic characterization and significance ot normal karyotyes in t(8;21) acute mveloblastic leukemia. Blood 59: 171–178. 1982.
Le Beau. M., Larson, R., Bitter, M., Vardiman, J.W., Golomb. H. and Rowley, JD. Association of an inversion of chromosome 16 with abnormal eosinophils in acute mvelomonocytic leukemia. N. Engl J Med 309: 630–636, 1983.
Miteiman F. Brandt L. Nilsson PG. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 52: 1229–1237. 1978.
Bain B. Catovsky D. O’Brien M. Spiers ASD, Richards HGH. Megakaryoblasticnd acute myeloproliferative syndrome following radiation therapy for non-Hodgkin’s lymphoma and transformation of chronic granulocytic leukaemia. J Clin Pathol 30: 235–242, 1977.
Breton-Gorius J, Reyes F, Vernant JP, Tulliez M. Dreyfus B. The blast crisis of chronic granulocytic leukaemia: Megakaryoblasric nature of cells as revealed by the presence of platelet-peroxidase. A cytocheinical ultrastructural studv. Br J Haematol 39: 295–303, 1978.
Rosenthal S, Cancllos GP. Gralnick HR. Erythroblastic transformation of chronic granulocytic leukemia. Am J Med 63:116–124, 1977.
Parkin JL, McKenna RW, Brunning RD. Philadelphia chromosome-positive blastic leukaemia: Ultrastructural and ultracytochemical evidence of basophil and mast cell differentiation. Br J Haematol 52: 663–677, 1982.
Prentice AF, Smith AG, Brandstock KF. Mixed lymphoblastic-myclomonoblastic leukemia in treated Hodgkin’s disease. Blood 56: 129–133. 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston/The Hague/Dordrecht/Lancaster
About this chapter
Cite this chapter
Vardiman, J.W., Bitter, M., Golomb, H. (1984). Features of Therapy-Related Leukemia and their Comparison with Leukemia de Novo and with the Blast Phase of Chronic Granulocytic Leukemia. In: Polliack, A. (eds) Human Leukemias. Developments in Oncology Series, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2823-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2823-0_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9785-7
Online ISBN: 978-1-4613-2823-0
eBook Packages: Springer Book Archive